Form 4 for BMY Bristol Myers Squibb
Accepted 2023-07-05 00:00:00 ET · period of report 2023-07-01 · accession 0000014272-23-000128 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-05 | 2023-07-01 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +9,357 | 52.0K | +22% | $0 |
| D | 2023-07-05 | 2023-07-01 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $63.95 | -4,787 | 47.2K | -9% | -$306.1K |
| D | 2023-07-05 | 2023-07-01 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | -9,357 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2023-07-01 | M | A | 9,357 | $0.00 | 52,032 | D | — | — | (F1) The restricted stock units vest in four equal installments beginning on July 1, 2020. |
| 2 | Common | Common Stock, $0.10 par value | 2023-07-01 | F | D | 4,787 | $63.95 | 47,245 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2023-07-01 | M | D | 9,357 | $0.00 | 0 | D | — · — to 2023-07-01 | 9,357 Common Stock, $0.10 par value | (F1) The restricted stock units vest in four equal installments beginning on July 1, 2020. (F3) Each restricted stock unit converts into one share of common stock upon vesting. |